Skip to content

Triple H ODC Trial

Determination of the Oxygen Dissociation Curve Under the Conditions of an Avalanche Burial With an Air Pocket

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04041531
Acronym
3H-ODC
Enrollment
30
Registered
2019-08-01
Start date
2019-08-26
Completion date
2020-02-10
Last updated
2020-09-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Avalanche, Landslide, or Mudslide, Hypercapnia, Hypothermia, Accidental, Hypoxia

Brief summary

In an avalanche burial with an air pocket hypercapnia (and hypoxia) develops within few minutes, hypercapnia increases the rate of cooling and therefore the development of hypothermia. The Triple H Syndrome (Hypoxia, Hypercapnia, Hypothermia) occurs. This specific combination of the three parameters is unique for avalanche burial with an air pocket. Every single parameter has a substantial effect on the hemoglobin-oxygen dissociation curve, but until now no study described the combination of these three parameters. This curve will be measured under these specific conditions in a specifically developed in vitro model, to quantify its shifts and to show if there are combined effects of pCO2 and temperature. The newly developed method will be validated in comparison with an established method. The project will be performed with whole blood, drawn by healthy volunteers, in an experimental setting. The samples will be blinded to the investigator and analyzed in a randomized manner.

Detailed description

The ODC is a function of pO2 and SO2. pO2, the independent variable, is plotted on the x axis, SO2 on the y axis. For the determination of this function, a pairwise measurement of pO2 and the corresponding SO2 is to be performed. Using nonlinear regression analysis, the ODC can be fitted to the measured points that describe the relation of pO2 and SO2 and characteristic parameters like p50 value and inflection points can be calculated. To measure the ODC under the conditions of the Triple H Syndrome (Hypoxie, Hypercapnia, Hypothermia), the temperature and the pCO2 have to be changed and controlled during the measurement. No commercially available instrument is able to obtain this. Therefore, we envisaged the development of an entirely new approach. In the 3H ODC trial venous blood will be drawn from 18 - 40 years old female and male volunteers by a unique venipuncture. The participants have to be in a fasted situation, ASA I and nonsmokers. The blood sample will be immediately pseudonymized and stored on ice and a venous blood gas analysis will be carried out (pH, Hb, COHb, MetHb, FHb). Simultaneous to the main measurement, 2,3 BPG will be quantified by an ELISA test and any unknown hemoglobinopathy will be excluded by Hemoglobin Electrophoresis. In the 3H ODC trial 4 different pCO2 levels and 4 different temperatures will be analyzed in the resulting 16 combinations. In each round a lot of ODCs will be measured, the measurement chamber will be filled with participants blood samples in a randomized manner. After the measurements, the blood samples will be discarded.

Interventions

OTHERblood sampling

venous blood sampling for oxygen affinity in-vitro test

Sponsors

Institute of Mountain Emergency Medicine
CollaboratorOTHER
Medical University Innsbruck
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
FACTORIAL
Primary purpose
BASIC_SCIENCE
Masking
SINGLE (Investigator)

Intervention model description

16 combinations of 4 levels of pCO2 and 4 levels of temperature will be assessed for each participant

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* 18-40 years * fasted situation * ASA I * Informed Consent

Exclusion criteria

* any drug abuse * any drug intake within the last 10 days * smoking * known hemoglobinopathy * relevant illness within last 14 days * relevant blood loss within last 14 days * pregnancy or breast-feeding * participation in any pharmacological study * exposure to high altitude (\> 3000 m) within last 4 weeks

Design outcomes

Primary

MeasureTime frameDescription
amount of p50 in different levels of hypercapnia and hypothermiaday 1amount of p50 in mmHg (p50 = pO2 when oxygen saturation of hemoglobin is 50%)

Secondary

MeasureTime frameDescription
amount of p50 shift due to sexday 1amount of p50 in mmHg (p50 = pO2 when oxygen saturation of hemoglobin is 50%)
amount of inflection point in different levels of hypercapnia and hypothermiaday 1amount of inflection point in mmHg

Countries

Austria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026